Exudative Pleural Effusions Diagnosis and Management

Definition and Classification

Exudative pleural effusions result from processes localized to the pleura, characterized by increased pleural membrane permeability or lymphatic obstruction, as stated by the American College of Radiology 2 and Praxis Medical Insights 1
Light's criteria are used to identify exudates with 98% sensitivity and 72% specificity, requiring at least one of the following, according to Thorax 3 and Praxis Medical Insights 4

Malignancy is the most common cause of exudative effusions, accounting for 26% of all pleural effusions, with malignant cells present in approximately 60% of cases, as reported by Praxis Medical Insights 1 and Thorax 3
Parapneumonic effusions and empyema are common causes of exudative effusions, representing 16% of all pleural effusions, with neutrophil predominance and high cell counts, according to Praxis Medical Insights 1 and Thorax 3
Tuberculosis causes exudative pleural effusions in 6% of cases, with lymphocyte predominance, and a positive tuberculin skin test with lymphocytic exudate may justify empirical treatment, as stated by Praxis Medical Insights 1
Uraemic pleuritis occurs in end-stage renal failure patients, with a prevalence of 24.7%, and often presents with a hemorrhagic exudate, according to the European Respiratory Journal 6 and Praxis Medical Insights 1

A pH <7.2 with normal blood pH indicates pleural infection, rheumatoid arthritis, malignancy, or esophageal rupture, as reported by Thorax 3 and Praxis Medical Insights 1
Glucose <3.3 mmol/l indicates empyema, rheumatoid disease, tuberculosis, malignancy, or esophageal rupture, according to Thorax 3 and Praxis Medical Insights 1
Elevated pleural fluid amylase suggests acute pancreatitis, pancreatic pseudocyst, esophageal rupture, or malignancy, as stated by Thorax 3 and Praxis Medical Insights 1

Misclassification of cardiac and liver transudates as exudates occurs in 25-30% of cases, and serum-effusion albumin gradient >1.2 g/dL can reclassify an effusion as a transudate when heart failure is suspected, according to Praxis Medical Insights 1 and 4
NT-proBNP levels >1500 μg/mL in serum or pleural fluid can accurately diagnose heart failure, as reported by Praxis Medical Insights 1 and 4

Apply Light's criteria to distinguish exudates from transudates, and for exudates, analyze cellular differential, measure pH, glucose, and amylase levels, and consider pleural biopsy or thoracoscopy if diagnosis remains unclear, as stated by Thorax 3, Praxis Medical Insights 1 and 4